U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07642414) titled 'A Comprehensive Digital Care Program for Migraine Management' on June 04.
Brief Summary: This study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exercise therapy, and a dedicated care team, in reducing migraine frequency among adults with episodic or chronic migraine.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Migraine
Migraine With Aura
Migraine Without Aura
Intervention:
DEVICE: Neuromodulation Wearable Device
The Neuromodulation Wearable Device is an FDA-cleare...